Recursion Pharmaceuticals
Price & Volume
Stats
See moreOpen | $5.88 |
Previous Close | $5.84 |
Day Range | $5.72-$5.94 |
52W Range | $3.79-$12.36 |
Market Cap | $2.3B |
Shares Short | 94M |
Financials
See moreRevenue (12 Mos) | $58.8M |
Revenue Growth (YoY) | -58.3% |
Gross Profit (12 Mos) | -$300.8M |
Diluted EPS | -$1.69 |
News
See moreYahoo Finance • 6 days ago
3 Monster Stocks to Hold for the Next 10 Years
Yahoo Finance • 7 days ago
Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025
Yahoo Finance • 14 days ago
Why Recursion Pharmaceuticals, Inc. (RXRX) Went Down On Monday?
Yahoo Finance • 17 days ago
Why Recursion Pharmaceuticals Inc. (RXRX) Soared Last Week?
About
CEO | Dr. Christopher C. Gibson Ph.D. |
CFO | Mr. Ben R. Taylor |
Address | 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 800 |
